These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19558487)

  • 41. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?
    McGuire BB; O'Brien MF; McLoughlin S; O'Malley KJ; Fitzpatrick JM
    Ir Med J; 2007 Apr; 100(4):428-9. PubMed ID: 17566476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
    Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
    BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.
    Donovan JL; Kay HE; Peters TJ; Abrams P; Coast J; Matos-Ferreira A; Rentzhog L; Bosch JL; Nordling J; Gajewski JB; Barbalias G; Schick E; Silva MM; Nissenkorn I; de la Rosette JJ
    Br J Urol; 1997 Nov; 80(5):712-21. PubMed ID: 9393291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
    Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
    Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
    Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. International Continence Society "Benign Prostatic Hyperplasia" Study: background, aims, and methodology.
    Abrams P; Donovan JL; de la Rosette JJ; Schäfer W
    Neurourol Urodyn; 1997; 16(2):79-91. PubMed ID: 9042670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting.
    Rosenberg MT; Staskin DR; Kaplan SA; MacDiarmid SA; Newman DK; Ohl DA
    Int J Clin Pract; 2007 Sep; 61(9):1535-46. PubMed ID: 17627768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STEP: simplified treatment of the enlarged prostate.
    Rosenberg MT; Miner MM; Riley PA; Staskin DR
    Int J Clin Pract; 2010 Mar; 64(4):488-96. PubMed ID: 20039975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
    Sausville J; Naslund M
    Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benign prostatic hyperplasia (BPH) management in the primary care setting.
    Kapoor A
    Can J Urol; 2012 Oct; 19 Suppl 1():10-7. PubMed ID: 23089343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
    Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
    Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New developments in the diagnosis of benign prostatic hyperplasia].
    Vaida M; Novac B; Gheorghiu V; Novac C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):88-96. PubMed ID: 19292085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Consensus on the clinical impact of the new scientific evidence available on benign prostatic hyperplasia].
    Cózar-Olmo JM; Hernández-Fenández C; Miñana-López B; Amón-Sesmero JH; Montlleó-González M; Rodríguez-Antolín A; Caballero-Martínez F
    Actas Urol Esp; 2012 May; 36(5):265-75. PubMed ID: 22475690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benign prostatic hyperplasia: clinical manifestations and evaluation.
    Santos Dias J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging.
    Grossfeld GD; Coakley FV
    Radiol Clin North Am; 2000 Jan; 38(1):31-47. PubMed ID: 10664665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of symptomatic BPH in the UK: who is treated and how?
    McNicholas TA
    Eur Urol; 1999; 36 Suppl 3():33-9. PubMed ID: 10559629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].
    Bschleipfer T; Oelke M; Rieken M
    Urologe A; 2019 Mar; 58(3):238-247. PubMed ID: 30796463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of symptomatic BPH in Italy: who is treated and how?
    Tubaro A; Montanari E
    Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.